FDA approval of the first device to use novel biomarkers of kidney damage to assess risk of acute kidney injury (AKI) potentially brings forward diagnosis of moderate-to-severe AKI to a time frame that could enable early intervention. Although the device awaits greater scrutiny, its approval marks the beginning of a new era.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
FDA news release. FDA allows marketing of the first test to assess risk of developing acute kidney injury [online], (2014).
Kidney Disease Improving Global Outcomes. KDIGO clinical practice guideline for acute kidney injury. Section 2: AKI Definition. Kidney Int. Suppl. 2, 7–24 (2012).
Hoste, E. A. et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol. Dial. Transpl. http://dx.doi.org/10.1093/ndt/gfu292.
Bihorac, A. et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am. J. Respir. Crit. Care Med. 189, 932–939 (2014).
Kashani, K. et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit. Care 17, R25 (2013).
McCullough, P. A. et al. Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib. Nephrol. 182, 5–12 (2013).
Nickolas, T. L. et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J. Am. Coll. Cardiol. 59, 246–255 (2012).
Pickering, J. W. & Endre, Z. H. Linking injury to outcome in acute kidney injury: a matter of sensitivity. PLoS ONE 8, e62691 (2013).
Endre, Z. H. et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int. 79, 1119–1130 (2011).
Endre, Z. H. & Pickering, J. W. Biomarkers and creatinine in AKI: the trough of disillusionment or the slope of enlightenment? Kidney Int. 84, 644–647 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Endre, Z., Pickering, J. Cell cycle arrest biomarkers win race for AKI diagnosis. Nat Rev Nephrol 10, 683–685 (2014). https://doi.org/10.1038/nrneph.2014.198
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2014.198
This article is cited by
-
Epidemiology of acute kidney injury in children worldwide, including developing countries
Pediatric Nephrology (2017)
-
Biomarkers and surrogate endpoints in kidney disease
Pediatric Nephrology (2016)
-
Insuffisance rénale aiguë périopératoire : quoi de neuf ?
Réanimation (2015)